Africa urgently needs to guarantee its own health security.

A look back at 2021 through the Sustainable Development Goals.

The extraordinary vaccination of more than four billion people, and the lack of access for many others, were major forces this year - while Omicron's arrival complicated things further.

Experience in grant-writing, data analysis and presentation will serve researchers well - even when they move away from academia.

Research has stalled, funds have evaporated and many scientists are still struggling to get out.

A high-profile replication study in cancer biology has obtained disappointing results. Scientists must redouble their efforts to find out why.

Ten people who helped shape science in 2021.

Fund and use 'living' reviews of the latest data to steer research practice and policy.

From Omicron to a Mars helicopter to an Alzheimer's firestorm, our news editors choose the defining moments in science and research this year.

Delhi court will scrutinize whether the pirate paper website falls foul of India's copyright law. The verdict could have implications for academic publishers further afield.

The decision to appoint a board of advisors is welcome - and urgent, given the twin challenges of COVID and climate change.

COVID researchers are working at breakneck speed to learn about the variant's transmissibility, severity and ability to evade vaccines.

The data are growing that booster jabs enhance protection - but their durability, impact and ability to quash the new variant are unknown.

What we eat needs to be nutritious and sustainable. Researchers are trying to figure out what that looks like around the world.

Nature's salary survey finds that industry researchers are more positive about their careers. Academia must raise its game.

Jen Lewendon's move from the United Kingdom for a postdoc restricted her travel and led to extended stints in quarantine. Here's what the experience taught her.

Researchers are racing to determine whether a fast-spreading variant in South Africa poses a threat to COVID vaccines' effectiveness.

Carbon-neutrality institutes, and other initiatives to support a pledge to achieve net zero by 2060, are popping up like mushrooms across China.

Most scientists love what they do, but job satisfaction levels hit a new low, Nature's survey finds.

Preprint data show that a three-dose combo of Soberana jabs has 92.4% efficacy in clinical trials.

An open letter signed by 145 female scientists from across the world expresses concern over recent dismissals of women leaders.